Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Westerlund, J.
Right arrow Articles by Bergsten, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Westerlund, J.
Right arrow Articles by Bergsten, P.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 51:S50-S52, 2002
© 2002 by the American Diabetes Association, Inc.


Section 1: Insulin Release: Some Molecular Requisites

Glucose-Dependent Promotion of Insulin Release From Mouse Pancreatic Islets by the Insulin-Mimetic Compound L-783,281

Johanna Westerlund1, Bryan A. Wolf2, and Peter Bergsten1

1 Department of Medical Cell Biology, Uppsala University, Sweden
2 Department of Pathology and Laboratory Medicine, the Children’s Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania

An insulin-mimetic compound (L-783,281) was used in an attempt to determine the role of the ß-cell insulin receptor (IR) on insulin release. Islets were isolated from C57Bl/6j mice and cultured for 1 to 4 days. Insulin release from individual islets perifused in the presence of 3 mmol/l glucose was 10.5 ± 1.4 pg/min. Addition of 10 µmol/l L-783,281 had no effect on the rate of insulin secretion. When L-783,281 was added to perifusion medium containing 11 mmol/l glucose, the insulin-mimetic compound significantly increased insulin release. Insulin release from the isolated islet is pulsatile. In the presence of 3 mmol/l glucose, addition of L-783,281 significantly decreased the frequency of the oscillations from 0.35 ± 0.03 to 0.22 ± 0.04 oscillations/min. Addition of L-783,281 to perifusion medium containing 11 mmol/l glucose had no effect on the frequency of the insulin pulses (0.30 ± 0.05 oscillations/min). These results indicate that activation of the ß-cell IR by L-783,281 augments insulin release in the presence of a stimulatory glucose concentration. At nonstimulatory glucose concentrations, activation of the ß-cell IR may affect mechanisms related to the frequency of the insulin pulses.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Srivastava and H. J. Goren
Insulin Constitutively Secreted by {beta}-Cells Is Necessary for Glucose-Stimulated Insulin Secretion
Diabetes, August 1, 2003; 52(8): 2049 - 2056.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. D. Borge Jr. and B. A. Wolf
Insulin Receptor Substrate 1 Regulation of Sarco-endoplasmic Reticulum Calcium ATPase 3 in Insulin-secreting beta -Cells
J. Biol. Chem., March 21, 2003; 278(13): 11359 - 11368.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. D. Borge, J. Moibi, S. R. Greene, M. Trucco, R. A. Young, Z. Gao, and B. A. Wolf
Insulin Receptor Signaling and Sarco/Endoplasmic Reticulum Calcium ATPase in {beta}-Cells
Diabetes, December 1, 2002; 51(90003): S427 - 433.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2002 by the American Diabetes Association.